# Can Dr Oz CBD Gummies Really Help With Hair Loss And Insomnia? Let’s Get To The Root > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-gummies-hair-loss-research-evidence-review/ > **Published:** 2026-10-20T07:00:00-04:00 | **Last Modified / Clinically Audited:** 2026-09-17T15:59:24-04:00 > **Clinical Summary:** This article examines cbd gummies hair loss research and their purported benefits for insomnia. While marketing claims are widespread, clinical evidence remains --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic CbdSleepMarketing ClaimsHair LossConsumer Education Why This Matters Celebrity-endorsed [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) frequently make unsubstantiated health claims that can mislead patients and complicate clinical decision-making. This represents a pattern of marketing that exploits consumer trust while lacking peer-reviewed evidence for specific conditions like androgenetic alopecia or sleep disorders. Clinical Summary Celebrity-endorsed CBD gummies claiming efficacy for hair loss and insomnia lack clinical trial evidence supporting these specific indications. While CBD has demonstrated anxiolytic properties in controlled studies, there are no randomized controlled trials establishing efficacy for androgenetic alopecia. The hair loss-CBD connection appears to be entirely marketing-driven rather than evidence-based, and sleep benefits from CBD remain inconsistent across studies with significant placebo responses. Dr. Caplan’s Take “When patients ask about celebrity-endorsed CBD products, I redirect them to evidence-based options and remind them that marketing claims rarely align with clinical reality. These products typically contain minimal CBD doses and make therapeutic promises that simply aren’t supported by research.” Clinical Perspective 🧠 Patients considering [CBD for sleep](https://cedclinic.com/cannabis-insomnia-guide-tailored-sleep-solutions/) should explore products with documented dosing and third-party testing rather than celebrity endorsements. For hair loss specifically, there are established medical treatments with proven efficacy that should be prioritized. When evaluating any CBD product, clinicians should emphasize the importance of independent lab testing and realistic expectations based on current evidence. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Can%20Dr%20Oz%20CBD%20Gummies%20Really%20Help%20With%20Hair%20Loss%20And%20Insomnia%3F%20Let%27s%20Get%20To%20The%20...%20%40drcaplan&url=https%3A//fathomjournal.org/u8d2zjs2-vkqq-efcbd8y1-kdof-9kb3)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//fathomjournal.org/u8d2zjs2-vkqq-efcbd8y1-kdof-9kb3)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Can%20Dr%20Oz%20CBD%20Gummies%20Really%20Help%20With%20Hair%20Loss%20And%20Insomnia%3F%20Let%27s%20Get%20To%20The%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//fathomjournal.org/u8d2zjs2-vkqq-efcbd8y1-kdof-9kb3)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://fathomjournal.org/u8d2zjs2-vkqq-efcbd8y1-kdof-9kb3](https://fathomjournal.org/u8d2zjs2-vkqq-efcbd8y1-kdof-9kb3) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this CBD news?](#What_is_the_clinical_relevance_rating_of_this_CBD_news) - [What health conditions does this article cover in relation to CBD?](#What_health_conditions_does_this_article_cover_in_relation_to_CBD) - [Why are marketing claims about CBD being highlighted?](#Why_are_marketing_claims_about_CBD_being_highlighted) - [Is this information from a clinical source?](#Is_this_information_from_a_clinical_source) - [What should clinicians take away from this “Notable Clinical Interest” rating?](#What_should_clinicians_take_away_from_this_8220Notable_Clinical_Interest8221_rating) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this CBD news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings or policy developments are emerging and worth monitoring closely by healthcare professionals. #### What health conditions does this article cover in relation to CBD? Based on the article tags, this piece covers CBD’s potential applications for sleep disorders and hair loss conditions. These represent two distinct therapeutic areas where CBD marketing claims are being examined. #### Why are marketing claims about CBD being highlighted? The “Marketing Claims” tag suggests this article examines or evaluates promotional statements made about CBD products. This is clinically relevant as healthcare providers need accurate information to distinguish between evidence-based benefits and unsubstantiated marketing assertions. #### Is this information from a clinical source? Yes, this appears to be from CED Clinic, which seems to be a clinical education or research platform. The structured clinical relevance rating system suggests this is designed for healthcare professionals seeking [evidence-based cannabis](https://cedclinic.com/jama-cannabis-review-physician-analysis/) information. #### What should clinicians take away from this “Notable Clinical Interest” rating? The rating indicates these are emerging findings that warrant attention but may not yet represent established clinical practice. Clinicians should monitor developments in this area while maintaining evidence-based approaches to [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Discover recent clinical findings on cannabis and its impact on patient health outcomes, providing context for CBD research. [Read More](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) [CBD for Skin Care: Evidence-Based Benefits & Research](https://cedclinic.com/cbd-for-skin-care-evidence-based-benefits-research/) Explore evidence-based research on CBD's benefits for skin care, relevant to understanding topical and systemic effects. [Learn More](https://cedclinic.com/cbd-for-skin-care-evidence-based-benefits-research/) [Using Cannabis for Sleep Isn't as Harmless as It Seems: What to Know](https://cedclinic.com/using-cannabis-for-sleep-isnt-as-harmless-as-it-seems-what-to-know/) Review important considerations and clinical evidence regarding [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) for sleep disorders and insomnia. [Discover Insights](https://cedclinic.com/using-cannabis-for-sleep-isnt-as-harmless-as-it-seems-what-to-know/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).